CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 36602-36949
Annnotations
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T185","span":{"begin":0,"end":347},"obj":"Sentence"}],"text":"The relevance of IL-6-mediated neuroprotection to MS remains to be delineated, but the concentrations of IL-6 receptor components are altered in the cerebrospinal fluid and serum of patients with MS (Padberg et al., 1999) , suggesting that IL-6 signaling may be important to protect neurons during a demyelinating insult (Ransohoff et al., 2002) ."}
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T185","span":{"begin":0,"end":347},"obj":"Sentence"},{"id":"TextSentencer_T185","span":{"begin":0,"end":347},"obj":"Sentence"},{"id":"T271","span":{"begin":0,"end":347},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The relevance of IL-6-mediated neuroprotection to MS remains to be delineated, but the concentrations of IL-6 receptor components are altered in the cerebrospinal fluid and serum of patients with MS (Padberg et al., 1999) , suggesting that IL-6 signaling may be important to protect neurons during a demyelinating insult (Ransohoff et al., 2002) ."}
Epistemic_Statements
{"project":"Epistemic_Statements","denotations":[{"id":"T84","span":{"begin":0,"end":347},"obj":"Epistemic_statement"}],"text":"The relevance of IL-6-mediated neuroprotection to MS remains to be delineated, but the concentrations of IL-6 receptor components are altered in the cerebrospinal fluid and serum of patients with MS (Padberg et al., 1999) , suggesting that IL-6 signaling may be important to protect neurons during a demyelinating insult (Ransohoff et al., 2002) ."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T138","span":{"begin":50,"end":52},"obj":"Disease"},{"id":"T139","span":{"begin":196,"end":198},"obj":"Disease"}],"attributes":[{"id":"A138","pred":"mondo_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A139","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"The relevance of IL-6-mediated neuroprotection to MS remains to be delineated, but the concentrations of IL-6 receptor components are altered in the cerebrospinal fluid and serum of patients with MS (Padberg et al., 1999) , suggesting that IL-6 signaling may be important to protect neurons during a demyelinating insult (Ransohoff et al., 2002) ."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T76","span":{"begin":300,"end":313},"obj":"Phenotype"}],"attributes":[{"id":"A76","pred":"hp_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/HP_0011096"}],"text":"The relevance of IL-6-mediated neuroprotection to MS remains to be delineated, but the concentrations of IL-6 receptor components are altered in the cerebrospinal fluid and serum of patients with MS (Padberg et al., 1999) , suggesting that IL-6 signaling may be important to protect neurons during a demyelinating insult (Ransohoff et al., 2002) ."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T87","span":{"begin":149,"end":168},"obj":"Body_part"},{"id":"T88","span":{"begin":173,"end":178},"obj":"Body_part"}],"attributes":[{"id":"A87","pred":"uberon_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"},{"id":"A88","pred":"uberon_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"The relevance of IL-6-mediated neuroprotection to MS remains to be delineated, but the concentrations of IL-6 receptor components are altered in the cerebrospinal fluid and serum of patients with MS (Padberg et al., 1999) , suggesting that IL-6 signaling may be important to protect neurons during a demyelinating insult (Ransohoff et al., 2002) ."}